Morten Baltzer Houlind

Morten Baltzer Houlind

Postdoc


Publication year:
All
31 - 33 out of 33Page size: 10
  1. 2022
  2. Published

    Soluble urokinase plasminogen activator receptor and decline in kidney function among patients without kidney disease

    Iversen, E., Kallemose, T., Hornum, Mads, Bengaard, A. K., Nehlin, J. O., Rasmussen, L. J. H., Sandholdt, H., Tavenier, J., Feldt-Rasmussen, Bo, Andersen, Ove, Eugen-Olsen, J. & Houlind, Morten Baltzer, 2022, In: Clinical Kidney Journal. 15, 8, p. 1534-1541

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Acute and Long-Term Treatment With Dapagliflozin and Association With Serum Soluble Urokinase Plasminogen Activator Receptor

    Rotbain Curovic, V., Houlind, Morten Baltzer, Hansen, T. W., Eugen-Olsen, J., Laursen, J. C., Eickhoff, M. K., Persson, F. & Rossing, Peter, 2022, In: Frontiers in Pharmacology. 13, 799915.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Incidence of hospital contacts with acute kidney injury after initiation of second-generation antipsychotics in older adults: a Danish population-based cohort study

    Sharon, R., Lange, Theis, Aakjær, Mia, Brøgger Kristiansen, S., Houlind, Morten Baltzer & Andersen, Morten, 2022, In: European Journal of Clinical Pharmacology. 78, p. 1341–1349 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 Next

ID: 283951172